Position in TMO
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$809,544,502
-$434,706,164 QoQ
Shares Held
1,646,989
-23.3% QoQ
Ownership
0.443%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 99.95057647622419.ToString("F0")%
Shared 0.ToString("F0")%
None 0.049423523775811495.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Nuveen, LLC holds $2,993,160,257 across 30 Diagnostics & Research names. TMO ranks #2 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
5,334,755 | $1,011,469,546 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,646,989 | $809,544,502 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
445,804 | $250,492,808 | |
| 4 | A |
Agilent Technologies, Inc.
|
865,669 | $98,668,951 | |
| 5 | NTRA |
Natera, Inc.
|
474,608 | $94,916,853 | |
| 6 | DGX |
Quest Diagnostics Inc
|
465,425 | $91,213,989 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
68,803 | $86,774,343 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
494,490 | $84,330,323 |
All Filings in TMO
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $809,544,502 | 1,646,989 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $1,244,250,666 | 2,147,296 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $631,100,748 | 1,301,185 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $474,880,833 | 1,171,215 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $532,360,345 | 1,069,856 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||